NCT03153488

Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Massachusetts General Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

This is a 6-month trial in adults to find out if certain neuromarkers can predict individual treatment response to stimulant medications for Attention Deficit Hyperactivity Disorder (ADHD). Males and females, ages 18-45, will complete an MRI scan at MIT prior to beginning medication for ADHD as determined by a treating clinician outside the context of this study.

Conditions

• Attention Deficit Hyperactivity Disorder

Interventions

Type	Name	Description
RADIATION	MRI	All participants will perform one MRI session before initiation of treatment. The imaging session will last about an hour including the structural and functional MRI portions. The subjects lie on a padded scanner couch in a dimly illuminated room, and wear foam earplugs to attenuate scanner sounds.

Timeline

• Start date: 2018-07-01
• Primary completion: 2023-07-01
• Completion: 2023-12-01
• First posted: 2017-05-15
• Last updated: 2022-09-26

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study